Psoriatic lesions affecting the scalp, nails, palms, and the soles of the feet are described as
difficult-to-treat psoriasis and require specific management. Involvement of these sites often …

Introduction: Nail psoriasis plays a major role in the overall assessment of psoriatic disease.
Four biologic agents are officially labeled for the treatment of moderate to severe, stable …

Biologic therapy is a well-established strategy for managing moderate and severe psoriasis.
Nevertheless, the high cost of such therapy, the relatively short span of clinical experience …

Background: Since the advent of biologic therapies for psoriasis, reports of efficacy in nail
psoriasis have appeared in the literature and at international conferences with increasing …

BACKGROUND AND OBJECTIVES: Biologic therapy has represented a major advance in
the treatment of moderate to severe psoriasis but its use depends upon the characteristics of …

The comparative efficacy of registered anti-psoriatic biologics and small molecules in
treating nail symptoms has not been systematically evaluated. The aim of this study was to …

Background Nail psoriasis occurs in about 50% of psoriatic patients and can be
psychologically devastating since it appears on visible areas. Up to now there is no …

Psoriasis vulgaris is an inflammatory skin disease that is generally chronic and that affects
between 1% and 2% of the population in industrialized Western countries. It is associated …

Introduction and objectives A great amount of information on systemic and biologic therapies
for moderate to severe psoriasis is now available. However, applying the evidence in …

Background Approximately 2% of people worldwide have psoriasis, with as many as 1
million people with psoriasis in Canada alone. 1, 2 The severity of psoriasis ranges from …